Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis
Open Access
- 21 April 2020
- journal article
- review article
- Published by Elsevier BV in Progress in Cardiovascular Diseases
- Vol. 63 (3), 271-307
- https://doi.org/10.1016/j.pcad.2020.03.011
Abstract
No abstract availableKeywords
This publication has 155 references indexed in Scilit:
- Corticosteroid Therapy for Cardiac Sarcoidosis: A Systematic ReviewCanadian Journal of Cardiology, 2013
- Selective In Vivo Visualization of Immune-Cell Infiltration in a Mouse Model of Autoimmune Myocarditis by Fluorine-19 Cardiac Magnetic ResonanceCirculation: Cardiovascular Imaging, 2013
- Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post ProcessingJournal of Cardiovascular Magnetic Resonance, 2013
- The Use of 18F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario ExperienceJournal of Nuclear Medicine, 2012
- Acute Adverse Reactions to Gadolinium-Based Contrast Agents in CMRJACC: Cardiovascular Imaging, 2011
- Detection of Myocardial Damage in Patients With SarcoidosisCirculation, 2009
- Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinationsJournal of Cardiovascular Magnetic Resonance, 2009
- ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive SummaryCirculation, 2008
- Follow-Up of Cardiac Sarcoidosis by Magnetic Resonance ImagingCirculation, 2005
- Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis.Cell Metabolism, 1978